Respiratory News and Research

RSS

Major new campaign launched in the UK to encourage flu and COVID-19 vaccinations

The UK Health Security Agency (UKHSA), Department of Health and Social Care and NHS England are urging those eligible who've not yet come forward for the flu and COVID-19 vaccines to 'get winter strong' and join the millions of others in taking up the offer ahead of the festive and new year season when flu and COVID-19 are expected to peak.

1 Nov 2023

Augmentation therapy can save lives of people with alpha-1 antitrypsin deficiency, study shows

Boosting levels of a deficient protein has clear survival benefits for people with the genetic condition alpha-1 antitrypsin deficiency (AATD), according to new research led by RCSI University of Medicine and Health Sciences.

1 Nov 2023

Hospitalization and mortality risks from COVID-19 by age during SARS-CoV-2 Delta and Omicron variants’ predominance

Age-stratified hospitalization and mortality risks from incident SARS-CoV-2 infections.

1 Nov 2023

Influence of employment during COVID-19 on cognitive and motor functions among elders

The effects of employment on geriatric health during the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) outbreak.

1 Nov 2023

Next-generation vaccine candidates protect against multiple strains of influenza and last longer

Recent preclinical results indicate novel next-generation vaccine candidates developed at Cleveland Clinic protect against multiple strains of influenza and last longer than vaccines currently in use.

31 Oct 2023

How next-gen sequencing is changing antibody drug discovery

New study outlines how next-generation sequencing (NGS) and machine-learning methods can revolutionize antibody discovery, particularly against SARS-CoV-2. The research demonstrates that NGS provides greater epitopic and paratopic diversity, enabling more effective identification and prioritization of therapeutic antibodies.

31 Oct 2023

Study reveals how SARS-CoV-2 alters mitochondria, leading to energy outages and organ failure

The lungs were once at the forefront of SARS-Cov-2 research, but as reports of organ failure and other serious complications poured in, scientists set out to discover how and why the respiratory virus was causing serious damage to the body's major organs, including the lungs.

31 Oct 2023

Understanding COVID-19 mortality in people with severe mental illness and different ethnicities

In a recent study published in the British Journal of Psychiatry, researchers evaluated mortality in individuals with severe mental illness (SMI) following COVID-19.

31 Oct 2023

COVID-19’s long reach: Some physical symptoms can persist up to two years post-diagnosis

Researchers investigated the prevalence rate of physical-type symptoms by the severity of acute COVID-19 beyond two years of diagnosis.

31 Oct 2023

Human-to-lion COVID transmission confirmed: Singapore study rings alarm bells for endangered species

The study reveals that the SARS-CoV-2 delta variant was transmitted from humans to lions at a Singapore zoo, emphasizing the risk to captive and endangered animals. The researchers call for strict infection control measures and suggest vaccinations for susceptible animals to protect them from anthropogenic viral transmissions.

30 Oct 2023

OU scientists receive $1.8 million to establish research center to address children's health impacts from environmental stressors

OU researchers have received a $1.8 million grant from the U.S. Environmental Protection Agency to establish a research center to address children's cumulative health impacts from agricultural and non-chemical exposures.

30 Oct 2023

New omicron sublineages surge, but Pfizer-BioNTech bivalent booster retains effectiveness

The efficacy of the bivalent Pfizer-BioNTech COVID-19 messenger ribonucleic acid (mRNA) vaccine BNT162b2 BA.4/5.

30 Oct 2023

Does adding sigh breaths to the usual care of trauma patients receiving mechanical ventilation increase ventilator-free days?

Researchers investigated whether adding sigh breaths to standard care regimens of mechanically ventilated trauma patients increased ventilator-free days.

30 Oct 2023

Diabetic patients with COVID-19: low antibody levels linked to worse outcomes

The role of anti-SARS-CoV-2 antibody levels on COVID-19 outcomes in patients with T2D.

30 Oct 2023

SARS-CoV-2 antigens stick around: Study finds virus markers can linger for over a year

Researchers found that SARS-CoV-2 antigens can persist in the body for up to 14 months after initial infection, challenging the idea that COVID-19 is a transient illness. This finding has implications for understanding long-term effects of the virus and could influence future treatments and vaccines.

30 Oct 2023

New study highlights risks of anti-ERBB2 cancer drugs during pregnancy

Study finds that anti-ERBB2 inhibitors used in breast cancer treatment pose significant risks to pregnancy and fetal health, including higher likelihoods of congenital defects and intrauterine growth restriction. Researchers recommend careful monitoring and possibly discontinuing these drugs during pregnancy despite their effectiveness against cancer.

29 Oct 2023

MHRA grants conditional marketing authorization for AbbVie's Tepkinly to treat aggressive blood cancer

AbbVie today announced that the UK Medicines and Healthcare products Regulatory Agency has granted conditional Marketing Authorisation for Tepkinly® (epcoritamab) as a monotherapy for the treatment of adults with relapsed or refractory (R/R) diffuse large B-cell lymphoma (DLBCL), after two or more systemic therapies.

28 Oct 2023

Reducing air pollution associated with lower risk of all-cause dementia and Alzheimer's disease

Previous reports have linked long-term air pollution exposure with accumulation of Alzheimer's disease-related brain plaques, but this is the first accumulated evidence that reducing pollution, especially fine particulates in the air and pollutants from the burning of fuel, is associated with lower risk of all-cause dementia and Alzheimer's disease.

27 Oct 2023

A new era of vaccines leaves old questions about prices unanswered

The world is entering a new era of vaccines. Following the success of covid-19 mRNA shots, scientists have a far greater capacity to tailor shots to a virus's structure, putting a host of new vaccines on the horizon.

27 Oct 2023

From education to politics: a pan-European analysis of COVID-19 conspiracy theory influences

People’s belief in COVID-19-related conspiracy theories (CTs) In Europe.

27 Oct 2023

Respiratory News and Research

Major new campaign launched in the UK to encourage flu and COVID-19 vaccinations

Augmentation therapy can save lives of people with alpha-1 antitrypsin deficiency, study shows

Hospitalization and mortality risks from COVID-19 by age during SARS-CoV-2 Delta and Omicron variants’ predominance

Influence of employment during COVID-19 on cognitive and motor functions among elders

Next-generation vaccine candidates protect against multiple strains of influenza and last longer

How next-gen sequencing is changing antibody drug discovery

Study reveals how SARS-CoV-2 alters mitochondria, leading to energy outages and organ failure

Understanding COVID-19 mortality in people with severe mental illness and different ethnicities

COVID-19’s long reach: Some physical symptoms can persist up to two years post-diagnosis

Human-to-lion COVID transmission confirmed: Singapore study rings alarm bells for endangered species

OU scientists receive $1.8 million to establish research center to address children's health impacts from environmental stressors

New omicron sublineages surge, but Pfizer-BioNTech bivalent booster retains effectiveness

Does adding sigh breaths to the usual care of trauma patients receiving mechanical ventilation increase ventilator-free days?

Diabetic patients with COVID-19: low antibody levels linked to worse outcomes

SARS-CoV-2 antigens stick around: Study finds virus markers can linger for over a year

New study highlights risks of anti-ERBB2 cancer drugs during pregnancy

MHRA grants conditional marketing authorization for AbbVie's Tepkinly to treat aggressive blood cancer

Reducing air pollution associated with lower risk of all-cause dementia and Alzheimer's disease

A new era of vaccines leaves old questions about prices unanswered

From education to politics: a pan-European analysis of COVID-19 conspiracy theory influences

Industry Focus eBook - Cell biology (5th edition) eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News